Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
jiuwei jinqiao granules
- Development stage
- Unknown
- Lead developer
- Shanghai Chunxiang Medical Technology
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Jiuwei Jinqiao Granules is a Traditional Chinese Medicine (TCM) candidate developed by Shanghai Chunxiang Pharmaceutical Technology Co., Ltd. for the treatment of acute simple appendicitis. Classified as a Category 1.1 new drug in China, it is formulated as an oral granule designed to address the "heat-toxicity and blood-stasis" syndrome, which is the TCM pathological framework for appendiceal inflammation. The preparation is a multi-ingredient herbal formula, with *Fagopyrum dibotrys* (Golden Buckwheat) serving as a key component known for its anti-inflammatory and anti-infective properties. Jiuwei Jinqiao Granules aims to provide a non-surgical pharmacological intervention for patients with uncomplicated appendicitis by reducing cecal inflammation and resolving localized blood stasis. It has progressed through Phase 2 and Phase 3 clinical trials in China to evaluate its efficacy and safety compared to standard care or placebo.
- Brand names
- Jiuwei Jinqiao Granules
- Other names
- 九味金荞颗粒
Beyond the preview
Go deeper on jiuwei jinqiao granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on jiuwei jinqiao granules.